Immunopotential of Pasteurella multocida bivalent outer membrane protein-based vaccine entrapped in aluminum hydroxide nanoparticles
- PMID: 35922692
- PMCID: PMC9679094
- DOI: 10.1007/s42770-022-00795-1
Immunopotential of Pasteurella multocida bivalent outer membrane protein-based vaccine entrapped in aluminum hydroxide nanoparticles
Abstract
Swine pasteurellosis is one of the most economically important diseases of pig caused by Pasteurella multocida (P. multocida) capsular types A and D. These organisms are commensals and opportunistic pathogens in the upper respiratory tract in pig. In the present study, we extracted whole outer membrane proteins (OMP) from P. multocida capsular types A and D and were mixed together in the ratio of 1:1 forming bivalent outer-membrane proteins. The bivalent OMP was adsorbed onto aluminum hydroxide nanoparticles. The size of aluminum hydroxide nanoparticles adsorbed outer membrane protein was found to be in the range of 125 to 130 nm. We observed that aluminum hydroxide nanoparticles adjuvanted bivalent OMP-based vaccine elicited quicker immune kinetics in terms of IgG response as compared to aluminum hydroxide microparticles adjuvanted bivalent bacterin vaccine against P. multocida capsular type A and D.
Keywords: Aluminum hydroxide; Nanoparticles; Outer membrane protein (OMP); Pasteurella multocida; Vaccine.
© 2022. The Author(s) under exclusive licence to Sociedade Brasileira de Microbiologia.
Figures










Similar articles
-
Diversity of avian Pasteurella multocida strains based on capsular PCR typing and variation of the OmpA and OmpH outer membrane proteins.Vet Microbiol. 2003 Feb 2;91(2-3):169-82. doi: 10.1016/s0378-1135(02)00300-0. Vet Microbiol. 2003. PMID: 12458166 Free PMC article.
-
Characterization and comparison of Pasteurella multocida strains associated with porcine pneumonia and atrophic rhinitis.J Med Microbiol. 2003 Jan;52(Pt 1):59-67. doi: 10.1099/jmm.0.05019-0. J Med Microbiol. 2003. PMID: 12488567
-
Characterisation of bovine strains of Pasteurella multocida and comparison with isolates of avian, ovine and porcine origin.Vet Microbiol. 2004 Apr 5;99(2):145-58. doi: 10.1016/j.vetmic.2003.11.013. Vet Microbiol. 2004. PMID: 15019106
-
Pasteurella multocida and bovine respiratory disease.Anim Health Res Rev. 2007 Dec;8(2):129-50. doi: 10.1017/S1466252307001399. Anim Health Res Rev. 2007. PMID: 18218157 Review.
-
Immunogens of Pasteurella.Vet Microbiol. 1993 Nov;37(3-4):353-68. doi: 10.1016/0378-1135(93)90034-5. Vet Microbiol. 1993. PMID: 8116191 Review.
Cited by
-
Global commercialization and research of veterinary vaccines against Pasteurella multocida: 2015-2022 technological surveillance.Vet World. 2023 May;16(5):946-956. doi: 10.14202/vetworld.2023.946-956. Epub 2023 May 9. Vet World. 2023. PMID: 37576757 Free PMC article.
References
-
- Varte Z, Dutta T, Roychoudhury P, Begum J, Chandra R (2014) Isolation, identification, characterization and antibiogram of Pasteurella multocida isolated from pigs in Mizoram with special reference to progressive atrophic rhinitis. Vet World 7. 10.14202/vetworld.2014.95-99
-
- Tamuly S, Kumar Saxena M, Saxena A, Kumar Mishra R, Jha R. Comparative evaluation of humoral immune response generated by calcium phosphate nanoparticle adjuvanted and saponin-adjuvanted recombinant outer membrane protein 87 (Omp87) of Pasteurella multocida (serotype B:2) in mice. J Nanopharmaceutics Drug Deliv. 2014;2(1):80–86. doi: 10.1166/jnd.2014.1045. - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources